A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder

Journal of Clinical Investigation

Volumn 103, Issue 4, 1999, Pages 497-505

  Liu, Yujing ^a,g   Wada, Ryuichi ^a   Kawai, Hiromichi ^a   Sango, Kazunori ^a   Deng, Chuxia ^a   Tai, Tadashi ^b   McDonald, Michael P ^c   Araujo, Kristlyn ^c   Crawley, Jacqueline N ^c   Bierfreund, Uwe ^d   Sandhoff, Konrad ^d   Suzuki, Kinuko ^e   Proia, Richard L ^a,f  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM2; GLYCOSPHINGOLIPID;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; ENZYME SUBSTRATE; GENETIC MODEL; KNOCKOUT MOUSE; LIPIDOSIS; MOUSE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STORAGE DISEASE;

EID: 0033557199     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5542     Document Type: Article

References (30)

1. Kolter, T., and Sandhoff, K. 1998. Recent advances in the biochemistry of sphingolipidoses. Brain Pathol. 8:79-100.
2. Neufeld, E.F. 1991. Lysosomal storage diseases. Annu. Rev. Biochem. 60:257-280.
3. Radin, N.S. 1996. Treatment of Gaucher disease with an enzyme inhibitor. Glycoconj. J. 13:153-157.
4. Platt, F.M., et al. 1997. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science. 276:428-431.
5. Sango, K., Johnson, O.N., Kozak, C.A., and Proia, R.L. 1995. β-1,4-N-acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene. Genomics. 27:362-365.
6. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:911-921.
7. Sango, K., et al. 1996. Mice lacking both subunits of lysosomal β-hexosaminidase exhibit mucopolysaccharidosis and gangliosidosis. Nat. Genet. 14:348-352.
8. Starr, C.M., Masada, R.I., Hague, C., Skop, E., and Klock, J.C. 1996. Fluorophore-assisted carbohydrate electrophoresis in the separation, analysis, and sequencing of carbohydrates. J. Chromatogr. A. 720:295-321.
9. Kotani, M., Ozawa, H., Kawashima, I., Ando, S., and Tai, T. 1992. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim. Biophys. Acta. 1117:97-103.
10. Ozawa, H., et al. 1997. Generation and characterization of mouse monoclonal antibodies specific for N-linked neutral oligosaccharides of glycoproteins. Arch. Biochem. Biophys. 342:48-57.
11. Sango, K., et al. 1995. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11:170-176.
12. Huang, J.Q., et al. 1997. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 6:1879-1885.
13. Capecchi, M.R. 1989. Altering the genome by homologous recombination. Science. 244:1288-1292.
14. Takamiya, K., et al. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA. 93:10662-10667.
15. Norflus, F., et al. 1998. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J. Clin. Invest. 101:1881-1888.
16. Suzuki, K., Proia, R.L., and Suzuki, K. 1998. Mouse models of human lysosomal diseases. Brain Pathol. 8:195-215.
17. M2 gangliosidoses. In The metabolic and molecular basis of inherited disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 2839-2879.
18. Yamanaka, S., et al. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA. 91:9975-9979.
19. Taniike, M., et al. 1995. Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease. Acta Neuropathol. 89:296-304.
20. Phaneuf, D., et al. 1996. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 5:1-14.
21. Brady, R.O. 1998. Therapy for the sphingolipidoses. Arch. Neurol. 55:1055-1056.
22. Beutler, E., and Grabowski, G.A. 1995. Gaucher disease. In The metabolic and molecular basis of inherited disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 2641-2670.
23. Krivit, W., et al. 1998. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Engl. J. Med. 338:1119-1126.
24. Hoogerbrugge, P.M., et al. 1995. Allogeneic bone marrow transplantation for lysosomal storage diseases (comment). Lancet. 345:1398-1402.
25. Platt, F.M., Neises, G.R., Dwek, R.A., and Butters, T.D. 1994. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269:8362-8365.
26. Leinekugel, P., Michel, S., Conzelmann, E., and Sandhoff, K. 1992. Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88:513-523.
27. de Jong, J.G., et al. 1998. Oligosaccharide excretion in adult Gaucher disease. J. Inherit. Metab. Dis. 21:49-59.
28. Suzuki, K., Sango, K., Proia, R.L., and Langaman, C. 1997. Mice deficient in all forms of lysosomal β-hexosaminidise show mucoploysaccharidosis-like phenotype. J. Neuropathol. Exp. Neurol. 56:693-703.
29. M1 ganglioside and Morquio B disease. In The metabolic and molecular bases of inherited disease. Vol. II. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 2785-2823.
30. Sheikh, K.A., et al. 1998. Mice lacking complex gangliosides develop peripheral neuropathy. Soc. Neurosci. Abstr. 2:483 (Abstr.)